Second phase I trial DCVax-Brain in patients with glioblastoma.

Trial Profile

Second phase I trial DCVax-Brain in patients with glioblastoma.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Aug 2010

At a glance

  • Drugs Dendritic cell vaccine-Northwest Biotherapeutics (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Aug 2010 Follow-up data from pooled phase I and II trials reported in a Northwest Biotherapeutics media release.
    • 21 Oct 2009 Further follow-up data reported in a Northwest Biotherapeutics media release.
    • 02 Mar 2009 Long term follow-up data for the second half of 2008 reported in a Northwest Biotherapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top